Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-09-18

FDA Approved: HYDRALAZINE — Original Application (Nivagen Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original generic application for hydralazine hydrochloride tablets from Nivagen Pharmaceuticals, Inc., for the treatment of hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hydralazine hydrochloride (Hydralazine hydrochloride)

Snippet

ORIG AP for HYDRALAZINE (HYDRALAZINE HYDROCHLORIDE)